Reach Us +1-218-451-2974


Is Alzheimer?s Pathology Detrimental In Late-onset Dementia In Man? | 12537
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Is Alzheimer?s pathology detrimental in late-onset dementia in man?

International Conference on Psychology, Autism and Alzheimers Disease

Jonathan Williams

Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.004

Background: It is hard to test the role of Alzheimer pathology in man. Alzheimer himself believed that the pathology he described was epiphenomenal, but removing it is the basis of current therapeutic strategies. Most people with late-onset dementia have mixtures of pathologies. Analyzing interactions of Alzheimer pathology with co-existing pathologies presents an opportunity to test if it is detrimental. Surprisingly, published data show (mostly unreported) antagonism between Alzheimer and other pathologies. Methods: Appropriate statistical methods were used to disentangle the contributions of five degenerative pathologies (Alzheimer, vascular, Substantia Nigra degeneration, Lewy Bodies, Fronto-temporal lobar degeneration) or inflammatory markers to three clinical outcomes (cognitive decline, neuropsychiatric symptoms and survival). Specifically, I tested if (a) adverse effects of different pathologies were simply additive, synergistic or antagonistic and (b) Alzheimer pathology showed non-linear associations with outcomes. Results: Alzheimer pathology (a) antagonized adverse effects of every other pathology or inflammatory index on most outcomes and (b) showed an inverted-U relation to survival. Conclusions: In line with published data, Alzheimer pathology antagonized adverse effects of every observed non-Alzheimer pathology or inflammatory marker with which it coexisted. This ubiquitous antagonism was unique to Alzheimer pathology. Moreover, its inverted-U relation with survival is typical of a physiological marker, not a pathological one. Together, these results imply that Alzheimer pathology may be generally protective, so removing it may be unhelpful. Further studies should test if Alzheimer pathology antagonizes further factors that adversely affect brain function.
Jonathan Williams qualified as a physician from Cambridge and Birmingham Universities before completing his Ph.D. in Experimental Psychology at Oxford. He then trained in psychiatry and undertook postdoctoral studies that intercalated clinical and academic work at Oxford, including 10 years at The Oxford Project to Investigate Memory and Ageing (OPTIMA). He now works as a consultant in Psychiatry of Older Adults in Hamilton, New Zealand. He has published 40 refereed papers.